Kapur Anil — SEC Form 4 filings
SEC reporting owner CIK 1730703. 9 Form 4 filings on record with FilingPulse; latest filed 2026-05-26.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-16 to 2026-05-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 421,875 shares, $1,959,609 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 421,875 shares @ $4.64 ($1,959,609) in GERON CORP, filed 2024-06-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GERON CORP (GERN) | EVP, Corp Strategy & CCO | 3 | — | 1 leg · 421,875 sh · $1,959,609 | 4 |
| Verastem, Inc. (VSTM) | Director | 3 | — | — | 5 |
| Nurix Therapeutics, Inc. (NRIX) | Director | 3 | — | — | 3 |
Form 4 filings — Kapur Anil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-26 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2026-05-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 31,250 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 8,333 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-10-16 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 8,333 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | GERON CORP (GERN) | Option exercise (M): 421,875 @ $1.06 · Sale (S): 421,875 @ $4.64 · Option exercise (M): 421,875 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | GERON CORP (GERN) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | GERON CORP (GERN) | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1730703 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →